Our study has laid a foundation for future investigations to further explore the potential of RABEX-5 mRNA as a diagnostic marker for monitoring biochemical recurrence and as an effective therapeutic target for preventing and treating prostate cancer. Here, RABGEF1 is linked to prostate carcinoma.